ProPhase Labs, Inc.
PRPH
$0.05
$0.0120.05%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.63% | -8.17% | -52.93% | -212.76% | 111.54% |
| Total Depreciation and Amortization | -0.10% | -8.72% | -26.63% | -10.29% | -2.38% |
| Total Amortization of Deferred Charges | -86.09% | 255.08% | 102.10% | 28.23% | -25.90% |
| Total Other Non-Cash Items | 295.44% | -121.20% | 62.14% | 120.79% | -157.49% |
| Change in Net Operating Assets | -4.51% | 319.18% | -223.58% | 137.15% | -113.82% |
| Cash from Operations | 39.19% | 64.72% | -1,311.34% | 92.69% | 3.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 26.42% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Investing | -- | -- | -100.00% | -92.15% | 2,232.50% |
| Total Debt Issued | -41.38% | -77.81% | 431.74% | 381.86% | -86.65% |
| Total Debt Repaid | 82.04% | 83.72% | -50.20% | 33.60% | 14.11% |
| Issuance of Common Stock | -- | -- | -100.00% | -91.46% | 10.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -103.52% |
| Cash from Financing | -26.01% | -75.42% | 1,326.05% | -86.53% | -48.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.27% | -233.47% | 191.36% | 113.73% | -433.33% |